药品注册申请号:017563
申请类型:NDA (新药申请)
申请人:PFIZER
申请人全名:PFIZER INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 FLAVORED COLESTID COLESTIPOL HYDROCHLORIDE GRANULE;ORAL 5GM/PACKET Yes No None 1977/04/04 Approved Prior to Jan 1, 1982 Prescription
002 FLAVORED COLESTID COLESTIPOL HYDROCHLORIDE GRANULE;ORAL 5GM/SCOOPFUL Yes No None Approved Prior to Jan 1, 1982 Prescription
003 COLESTID COLESTIPOL HYDROCHLORIDE GRANULE;ORAL 5GM/SCOOPFUL Yes No AB 1995/09/22 Prescription
004 COLESTID COLESTIPOL HYDROCHLORIDE GRANULE;ORAL 5GM/PACKET Yes Yes AB 1995/09/22 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2018/04/25 SUPPL-24(补充) Approval Labeling STANDARD
2014/05/22 SUPPL-23(补充) Approval Labeling STANDARD
1996/03/26 SUPPL-19(补充) Approval Manufacturing (CMC) PRIORITY
1996/01/18 SUPPL-20(补充) Approval Manufacturing (CMC) PRIORITY
1995/09/22 SUPPL-21(补充) Approval Labeling STANDARD
1993/12/06 SUPPL-13(补充) Approval Manufacturing (CMC) PRIORITY
1992/06/01 SUPPL-15(补充) Approval Manufacturing (CMC) PRIORITY
1992/04/09 SUPPL-17(补充) Approval Labeling
1991/12/18 SUPPL-16(补充) Approval Labeling
1991/08/06 SUPPL-12(补充) Approval Labeling
1991/06/17 SUPPL-14(补充) Approval Labeling
1990/07/27 SUPPL-11(补充) Approval Labeling
1987/04/03 SUPPL-10(补充) Approval Manufacturing (CMC) PRIORITY
1986/11/24 SUPPL-9(补充) Approval Labeling
1985/02/25 SUPPL-7(补充) Approval Manufacturing (CMC) PRIORITY
1982/02/19 SUPPL-6(补充) Approval Labeling
1982/02/19 SUPPL-5(补充) Approval Labeling
1982/02/19 SUPPL-4(补充) Approval Labeling
1979/07/23 SUPPL-2(补充) Approval Manufacturing (CMC) PRIORITY
1979/04/17 SUPPL-3(补充) Approval Labeling
1977/05/16 SUPPL-1(补充) Approval Manufacturing (CMC) PRIORITY
1977/04/04 ORIG-1(原始申请) Approval Type 1 - New Molecular Entity PRIORITY
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:COLESTIPOL HYDROCHLORIDE 剂型/给药途径:GRANULE;ORAL 规格:5GM/SCOOPFUL 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
017563 003 NDA COLESTID COLESTIPOL HYDROCHLORIDE GRANULE;ORAL 5GM/SCOOPFUL Prescription Yes No AB 1995/09/22 PFIZER
077277 001 ANDA COLESTIPOL HYDROCHLORIDE COLESTIPOL HYDROCHLORIDE GRANULE;ORAL 5GM/SCOOPFUL Prescription No No AB 2006/05/02 IMPAX LABS
活性成分:COLESTIPOL HYDROCHLORIDE 剂型/给药途径:GRANULE;ORAL 规格:5GM/PACKET 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
017563 004 NDA COLESTID COLESTIPOL HYDROCHLORIDE GRANULE;ORAL 5GM/PACKET Prescription Yes Yes AB 1995/09/22 PFIZER
077277 002 ANDA COLESTIPOL HYDROCHLORIDE COLESTIPOL HYDROCHLORIDE GRANULE;ORAL 5GM/PACKET Prescription No No AB 2006/05/02 IMPAX LABS
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database